{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:49:50Z","timestamp":1791348590774,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xphs.2026.104491","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:09:53Z","timestamp":1788044993000},"page":"104491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nitrosamines and their precursors in pharmaceutical packaging and potential contamination for stability chambers"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2975-2448","authenticated-orcid":false,"given":"Lukas","family":"Jost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Sprau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Th\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payden","family":"Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4110-2897","authenticated-orcid":false,"given":"Lucas","family":"Shaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilig","family":"Sechin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gl\u00e4ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7941-3598","authenticated-orcid":false,"given":"David","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0760-7271","authenticated-orcid":false,"given":"Percy","family":"Kampeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7285-1290","authenticated-orcid":false,"given":"Weichun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104491_bib0001","series-title":"FDA updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan). FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan)","year":"2018"},{"key":"10.1016\/j.xphs.2026.104491_bib0002","series-title":"FDA Updates and Press Announcements on NDMA in Zantac (Ranitidine)","year":"2020"},{"issue":"6","key":"10.1016\/j.xphs.2026.104491_bib0003","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/0115680266278636240125113509","article-title":"Nitrosamine impurities in pharmaceuticals: an empirical review of their detection, mechanisms, and regulatory approaches","volume":"24","author":"Bhirud","year":"2024","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"10.1016\/j.xphs.2026.104491_bib0004","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5731\/pdajpst.2021.012645","article-title":"Evaluating nitrosamines from elastomers in pharmaceutical primary packaging","volume":"76","author":"Boltres","year":"2022","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.xphs.2026.104491_bib0005","series-title":"CDER Nitrosamine Impurity Acceptable Intake Limits","article-title":"CDER nitrosamine impurity acceptable intake limits","year":"2025"},{"issue":"3","key":"10.1016\/j.xphs.2026.104491_bib0006","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5731\/pdajpst.2025-000072.1","article-title":"Determination of trace nitrosamines in plastic pharmaceutical packaging materials","volume":"80","author":"Jost","year":"2026","journal-title":"PDA J Pharm Sci Technol"},{"issue":"5","key":"10.1016\/j.xphs.2026.104491_bib0007","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.xphs.2023.01.028","article-title":"Current threat of nitrosamines in pharmaceuticals and scientific strategies for risk mitigation","volume":"112","author":"Tuesuwan","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104491_bib0008","first-page":"1","article-title":"Risk assessment, detection and control of mutagenic impurities in pharmaceuticals: emphasis on nitrosamines","volume":"17","author":"Dande","year":"2025","journal-title":"Crit Rev Anal Chem"},{"issue":"9","key":"10.1016\/j.xphs.2026.104491_bib0009","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1021\/acs.oprd.0c00224","article-title":"Potential for the formation of N-nitrosamines during the manufacture of active pharmaceutical ingredients: an assessment of the risk posed by trace nitrite in water","volume":"24","author":"Ashworth","year":"2020","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2026.104491_bib0010","unstructured":"Nitrosamine impurities: guidance for marketing authorisation holders, European Medicines Agency (EMA). Nitrosamine Impurities: Guidance for Marketing Authorisation HoldersEuropean Medicines Agency (EMA) Accessed 10 July 2025."},{"key":"10.1016\/j.xphs.2026.104491_bib0011","series-title":"Stability Testing of New Drug Substances and Products","year":"2023"},{"issue":"4","key":"10.1016\/j.xphs.2026.104491_bib0012","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/jaoacint\/qsaf031","article-title":"Development and validation of a sensitive LC-MS\/MS method for simultaneous determination of several nitrosamines in large volume parenteral","volume":"108","author":"Jost","year":"2025","journal-title":"J AOAC Int"},{"key":"10.1016\/j.xphs.2026.104491_bib0013","series-title":"Biological Evaluation of Medical Devices Part 12: Sample preparation and Reference Materials","year":"2021"},{"key":"10.1016\/j.xphs.2026.104491_bib0014","series-title":"General Chapter (665\u3009 Plastic Components and Systems Used to Manufacture Pharmaceutical Drug Products and Biopharmaceutical Drug Substances and Products. USP-NF","year":"2022"},{"key":"10.1016\/j.xphs.2026.104491_bib0015","series-title":"General Chapter (1665) Characterization and Qualification of Plastic Components and Systems Used to Manufacture Pharmaceutical Drug Products and Biopharmaceutical Drug Substances and Products. USP-NF","year":"2022"},{"key":"10.1016\/j.xphs.2026.104491_bib0016","article-title":"Technical guidance for compatibility study of chemical drugs and elastomer seals","year":"2018","journal-title":"\u6307\u5bfc\u539f\u5219\u4e13\u680f"},{"key":"10.1016\/j.xphs.2026.104491_bib0017","unstructured":"ICH Guideline (2023). Validation of Analytical Procedures. Q2 (R2) ICH_Q2(R2)_Guideline_2023_1130.pdf"},{"key":"10.1016\/j.xphs.2026.104491_bib0018","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.talanta.2014.08.003","article-title":"Determination of secondary and tertiary amines as N-nitrosamine precursors in drinking water system using ultra-fast liquid chromatography-tandem mass spectrometry","volume":"131","author":"Wu","year":"2015","journal-title":"Talanta"},{"key":"10.1016\/j.xphs.2026.104491_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113573","article-title":"HILIC-MS determination of dimethylamine in the active pharmaceutical ingredients and in the dosage forms of metformin","volume":"191","author":"Dou\u0161a","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2026.104491_bib0020","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1039\/a902587a","article-title":"Determination of ammonia and aliphatic amines in environmental aqueous samples utilizing pre-column derivatization to their phenylthioureas and high performance liquid chromatography","volume":"124","author":"Sahasrabuddhey","year":"1999","journal-title":"Analyst"},{"issue":"15","key":"10.1016\/j.xphs.2026.104491_bib0021","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1016\/S0043-1354(03)00289-6","article-title":"A N-nitrosodimethylamine (NDMA) precursor analysis for chlorination of water and wastewater","volume":"37","author":"Mitch","year":"2003","journal-title":"Water Res"},{"issue":"7","key":"10.1016\/j.xphs.2026.104491_bib0022","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/es026070i","article-title":"Precursors of N-nitrosodimethylamine in natural waters","volume":"37","author":"Gerecke","year":"2003","journal-title":"Environ Sci Technol"},{"issue":"12","key":"10.1016\/j.xphs.2026.104491_bib0023","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/15298668091425833","article-title":"Aqueous extraction of N-nitrosamines from elastomers","volume":"41","author":"Ireland","year":"1980","journal-title":"Am Ind Hyg Assoc J"},{"key":"10.1016\/j.xphs.2026.104491_bib0024","series-title":"Process for the Preparation of Tris(2,4-Ditert-Butylphenyl)-Phosphite","author":"Maul","year":"1993"},{"key":"10.1016\/j.xphs.2026.104491_bib0025","series-title":"Method for Producing Organoacylphosphites","author":"Ortmann","year":"2005"},{"issue":"4","key":"10.1016\/j.xphs.2026.104491_bib0026","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00894-010-0750-4","article-title":"Theoretical investigation of reactivities of amines in the N-nitrosation reactions by N2O3","volume":"17","author":"Sun","year":"2011","journal-title":"J Mol Model"},{"issue":"6","key":"10.1016\/j.xphs.2026.104491_bib0027","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/tx990138z","article-title":"Carbon dioxide but not bicarbonate inhibits N-nitrosation of secondary amines. Evidence for amine carbamates as protecting entities","volume":"13","author":"Kirsch","year":"2000","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.xphs.2026.104491_bib0028","article-title":"N-nitrosamine risk assessment in pharmaceuticals: where are we from a regulatory point of view in 2025?","volume":"6","author":"Zhang","year":"2025","journal-title":"J Pharma Biomed Anal"},{"key":"10.1016\/j.xphs.2026.104491_bib0029","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/1522-2675(200205)85:5<1416::AID-HLCA1416>3.0.CO;2-I","article-title":"UV direct photolysis of N-nitrosodimethylamine (NDMA): kinetic and product study","volume":"85","author":"Stefan","year":"2002","journal-title":"HCA"},{"key":"10.1016\/j.xphs.2026.104491_bib0030","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s11434-008-0471-6","article-title":"Photodegradation of N-nitrosodiethylamine in water with UV irradiation","volume":"53","author":"Xu","year":"2008","journal-title":"Chin Sci Bull"},{"key":"10.1016\/j.xphs.2026.104491_bib0031","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijggc.2016.06.009","article-title":"Degradation and fate of N-nitrosamines in water by UV photolysis","volume":"52","author":"Afzal","year":"2016","journal-title":"Int J Greenh Gas Control"},{"issue":"9","key":"10.1016\/j.xphs.2026.104491_bib0032","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/carcin\/4.9.1147","article-title":"Occupational nitrosamine exposure. 1. Rubber and tyre industry","volume":"4","author":"Spiegelhalder","year":"1983","journal-title":"Carcinogenesis"},{"issue":"4412","key":"10.1016\/j.xphs.2026.104491_bib0033","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.472741","article-title":"N-nitrosamines in the rubber and tire industry","volume":"205","author":"Fajen","year":"1979","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.xphs.2026.104491_bib0034","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1248\/cpb.c20-00431","article-title":"Temperature-dependent formation of N-nitrosodimethylamine during the storage of ranitidine reagent powders and tablets","volume":"68","author":"Abe","year":"2020","journal-title":"Chem Pharm Bull"},{"issue":"12","key":"10.1016\/j.xphs.2026.104491_bib0035","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acs.oprd.0c00462","article-title":"Ranitidine\u2014investigations into the root cause for the presence of N-nitroso-N,N-dimethylamine in Ranitidine hydrochloride drug substances and associated drug products","volume":"24","author":"King","year":"2020","journal-title":"Org Proc Res Dev"},{"issue":"5","key":"10.1016\/j.xphs.2026.104491_bib0036","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.xphs.2023.01.027","article-title":"N-nitrosamine formation in pharmaceutical solid drug products: experimental observations","volume":"112","author":"Moser","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104491_bib0037","unstructured":"National Center for Biotechnology Information. N-nitrosodimethylamine. PubChem compound summary for CID 6124. Retrieved May 5, 2025, from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/6124."},{"key":"10.1016\/j.xphs.2026.104491_bib0038","unstructured":"National Center for Biotechnology Information. N-nitrosodibutylamine. PubChem compound summary for CID 13542. Retrieved May 5, 2025, from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/13542."},{"key":"10.1016\/j.xphs.2026.104491_bib0039","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.scitotenv.2019.03.281","article-title":"Formation potential of nine nitrosamines from polyacrylamide during chloramination","volume":"670","author":"Tan","year":"2019","journal-title":"Sci Total Environ"},{"issue":"8","key":"10.1016\/j.xphs.2026.104491_bib0040","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1021\/acs.est.1c01757","article-title":"Correction for \"contribution of N-nitrosamines and their precursors to domestic sewage by Greywaters and Blackwaters\"","volume":"55","author":"Zeng","year":"2021","journal-title":"Environ Sci Technol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104491_bib0041","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1021\/ac701804y","article-title":"Analysis of nitrosamines in wastewater: exploring the trace level quantification capabilities of a hybrid linear ion trap\/orbitrap mass spectrometer","volume":"80","author":"Krauss","year":"2008","journal-title":"Anal Chem"},{"key":"10.1016\/j.xphs.2026.104491_bib0042","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jpba.2017.10.035","article-title":"Artifactual degradation of secondary amine-containing drugs during accelerated stability testing when saturated sodium nitrite solutions are used for humidity control","volume":"149","author":"Sluggett","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2026.104491_bib0043","doi-asserted-by":"crossref","DOI":"10.1002\/chem.71416","article-title":"Air-water interface enhance the formation of N-centered radicals from amine oxidation","author":"Xu","year":"2026","journal-title":"Chem Eur J"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:52:15Z","timestamp":1791345135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022354926003412"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104491","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitrosamines and their precursors in pharmaceutical packaging and potential contamination for stability chambers","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104491"}}